{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:54:24Z","timestamp":1768316064227,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["228774"],"award-info":[{"award-number":["228774"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["10001271"],"award-info":[{"award-number":["10001271"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jid.2025.07.012","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T19:40:15Z","timestamp":1756237215000},"page":"296-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathogenic T Follicular Helper Cells in Bullous Pemphigoid: Lessons from a Murine Model"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3409-512X","authenticated-orcid":false,"given":"Paul","family":"Engeroff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.07.012_bib1","article-title":"Rituximab, omalizumab, and dupilumab treatment outcomes in bullous pemphigoid: a systematic review","volume":"13","author":"Cao","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.07.012_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2025.07.012_bib3","article-title":"IL-1R2 expression in Tfr cells controls allergic anaphylaxis by regulating IgG versus IgE responses [e-pub ahead of print]","author":"Engeroff","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jid.2025.07.012_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jdermsci.2025.04.006","article-title":"BAFF modulates T follicular helper cell differentiation through the BAFFR-PI3K\/AKT-mTOR signaling pathway in bullous pemphigoid","volume":"119","author":"Li","year":"2025","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jid.2025.07.012_bib5","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jaci.2018.03.014","article-title":"Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects","volume":"142","author":"Muramatsu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.07.012_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bjd\/ljae355","article-title":"Polarization of circulating follicular helper T cells correlates with bullous pemphigoid severity","volume":"192","author":"P\u00e9rals","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.07.012_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"Treg cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2025.07.012_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jid.2025.06.1583","article-title":"Autoreactive T follicular helper cells drive induction of bullous pemphigoid\u2014like skin disease","volume":"146","author":"Ramcke","year":"2026","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.07.012_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/jdv.20313","article-title":"Bullous pemphigoid burden of disease, management and unmet therapeutic needs","volume":"39","author":"Werth","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.07.012_bib10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41590-022-01253-8","article-title":"Targeting TFH cells in human diseases and vaccination: rationale and practice","volume":"23","author":"Yu","year":"2022","journal-title":"Nat Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25023140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25023140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:36:51Z","timestamp":1768297011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25023140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0022202X25023140"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.07.012","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenic T Follicular Helper Cells in Bullous Pemphigoid: Lessons from a Murine Model","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.06.1583","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}